SCHEMBL7700596

SCHEMBL7700596

CCNc1oc(-c2ccccc2C(F)(F)F)nc1S(=O)(=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.53
KMT2A Q03164 4/20 0.51
GAA P10253 2/20 0.51
MAPT P10636 7/20 0.50
ALDH1A1 P00352 7/20 0.48
HPGD P15428 3/20 0.48
KDM4E B2RXH2 3/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MEN1 O00255 2/20 0.47
UBE2N P61088 1/20 0.46
MAPK1 P28482 1/20 0.46
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7699708 0.91 L3MBTL1 (0.56) L3MBTL1KMT2AGAAMAPTALDH1A1
SCHEMBL7701108 0.87 KMT2A (0.62) L3MBTL1KMT2AGAAMAPTALDH1A1
SCHEMBL7699365 0.85 L3MBTL1 (0.75) L3MBTL1KMT2AGAAMAPTALDH1A1
SCHEMBL7698770 0.84 MAPT (0.61) KMT2AGAAMAPTALDH1A1KDM4E
SCHEMBL7695104 0.84 ALDH1A1 (0.58) L3MBTL1KMT2AGAAMAPTALDH1A1
SCHEMBL7696680 0.83 MAPT (0.62) KMT2AGAAMAPTALDH1A1HPGD
SCHEMBL7696767 0.82 ALDH1A1 (0.55) L3MBTL1KMT2AGAAMAPTALDH1A1
SCHEMBL7694777 0.82 MAPT (0.58) L3MBTL1KMT2AGAAMAPTALDH1A1
SCHEMBL7700470 0.81 KMT2A (0.44) L3MBTL1KMT2AGAAMAPTALDH1A1
SCHEMBL7697087 0.81 ALDH1A1 (0.64) KMT2AGAAMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100842-A1 SULFONYLOXAZOLAMINES AND THEIR USE AS 5-HT6 LIGANDS MERCK PATENT GMBH (DE) 2002-12-19 WO claimed
WO-2002100842-A1 SULFONYLOXAZOLAMINES AND THEIR USE AS 5-HT6 LIGANDS MERCK PATENT GMBH (DE) 2002-12-19 WO disclosed